EMD-16144

Single-particle
3.2 Å
EMD-16144
3D View Gallery
Deposition: 15/11/2022
Map released: 28/06/2023
Last modified: 05/07/2023
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-16144
Download
3D volume (map.gz) Experimental metadata (xml)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 8bon summary report (pdf.gz) Map and 8bon FULL report (pdf.gz)
EMICSS annotations (xml)

Structure of the SARS-CoV-2 spike glycoprotein in complex with the macrocyclic peptide S1B3inL1

EMD-16144

Single-particle
3.2 Å
EMD-16144
3D View Gallery
Deposition: 15/11/2022
Map released: 28/06/2023
Last modified: 05/07/2023
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: synthetic construct, Severe acute respiratory syndrome coronavirus 2, Tequatrovirus T4
Sample: SARS-CoV-2 spike glycoprotein in complex with the macrocyclic peptide S1B3inL1
Fitted models: 8bon

Deposition Authors: Hurdiss DL , Drulyte I
A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike protein.
Thijssen V, Hurdiss DL , Debski-Antoniak OJ, Spence MA, Franck C , Norman A , Aggarwal A, Mokiem NJ, van Dongen DAA, Vermeir SW , Liu M , Li W , Chatziandreou M, Donselaar T, Du W , Drulyte I , Bosch BJ, Snijder J, Turville SG, Payne RJ , Jackson CJ, van Kuppeveld FJM, Jongkees SAK
(2023) PNAS , 120 , e2303292120 - e2303292120
PUBMED: 37339194
DOI: doi:10.1073/pnas.2303292120
ISSN: 1091-6490
ASTM: PNASA6
Grant Support: